Medicus Pharma (MDCX) Liabilities and Shareholders Equity (2023 - 2025)

Medicus Pharma (MDCX) has reported Liabilities and Shareholders Equity for 3 consecutive years, with $10.1 million the latest figure, recorded in Q4 2025.

• Liabilities and Shareholders Equity for Q4 2025 came in at $10.1 million, up 78.18% year-over-year; the trailing twelve-month figure through Dec 2025 was $37.6 million (up 566.41% YoY), and the FY2025 annual result was $10.1 million, up 78.18% from the prior year.
• Liabilities and Shareholders Equity was $10.1 million for Q4 2025 at Medicus Pharma, up from $10.0 million in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $11.9 million in Q2 2025 and troughed at $1.9 million in Q4 2023.
• Average Liabilities and Shareholders Equity over 3 years is $7.5 million, with a median of $7.8 million recorded in 2025.
• Year-over-year, Liabilities and Shareholders Equity jumped 198.29% in 2024 and surged 78.18% in 2025.
• Over 3 years, Liabilities and Shareholders Equity stood at $1.9 million in 2023, then surged by 198.29% to $5.6 million in 2024, then surged by 78.18% to $10.1 million in 2025.
• Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $10.1 million in Q4 2025, $10.0 million in Q3 2025, and $11.9 million in Q2 2025.